Clinical trial
IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced…
NCT00300586 · Hospices Civils de Lyon, Other · Completed
Key facts
| NCT number | NCT00300586 |
|---|---|
| Title | IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer |
| Official title | A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer Not Progressing on First Line Cisplatin-gemcitabine Chemotherapy Maintenance Chemotherapy With Gemcitabine or Sequential Treatment With Erlotinib |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stage IV Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | observation, gemcitabine, erlotinib |
| Enrollment | 842 |
| Start date | Jun 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Mar 9, 2006 |
| Last update posted | May 28, 2019 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: